International Journal of Surgery (IJS)-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2小时前 Goldman 来自山东省

前往app查看评论内容

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-04-15 一只生活在陆地的鱼来自四川省

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标
经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。

13 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-05-09 V:19317152305 来自广西

审稿速度:1.0 | 投稿命中率:50.0
经验分享：meta分析，letter 这个杂志还是不错的

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-02-03 ms2000002077912665

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：Meta分析;肠癌
经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？

28 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-03-15 新来的小李来自云南省

这个杂志写评论和letter居然都要送审，也是相当奇葩

13 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-04-29 ms3000000893685364 来自重庆

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：外科
经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article

7 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2023-10-29 ms9000002081735011 来自山东省

审稿速度:6.0 | 投稿命中率:25.0
经验分享：刚被拒来发篇经验贴供各位学者参考。
本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS，
7.31 submitted
8.1 under review
期间变动了很多次审稿结束
9.12 with editor
最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定
10.29 直接给我转投了
更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了
这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了

34 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-02-15 ms5000000507385055 来自广西

偏重的研究方向：手术方式
经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢

17 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-04-02 172132_4262 来自北京

偏重的研究方向：外科;围手术期;临床研究
经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗

18 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2204505, encodeId=0d532204505dd, content=前往app查看评论内容, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16956388344, createdName=Goldman, createdTime=Mon May 13 18:26:43 CST 2024, time=2小时前, status=0, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2198554, encodeId=f6a2219855491, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：临床手术;2型糖尿病足;多组学+临床实验室指标 经验分享：我是2024.03.01投稿，2024.03.19返修，两个审稿人，感觉很积极，小修，要求2024.04.09返修，由于有会议工作，申请延期，编辑给了我一个月，2024.05.09返修，我04.02返修后，目前with editor，不知道要不要送二审。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=416e5444898, createdName=一只生活在陆地的鱼, createdTime=Mon Apr 15 09:33:05 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2203765, encodeId=9cf52203e657f, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：meta分析，letter 这个杂志还是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202405/798b5a2e155d4b5d8899a12a3b95ceba-2rj0RwrqXSU9.jpg, createdBy=ccd89276320, createdName=V:19317152305, createdTime=Thu May 09 22:41:28 CST 2024, time=2024-05-09, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2185639, encodeId=f22f218563994, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：Meta分析;肠癌 经验分享：刚录用了一篇，12.19投稿，返修后1.29录用，但是现在交了费就没有后文了，有录用的友友们知道多久能收到proof么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=28, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=90305421914, createdName=ms2000002077912665, createdTime=Sat Feb 03 12:06:22 CST 2024, time=2024-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2193356, encodeId=14d02193356f9, content=这个杂志写评论和letter居然都要送审，也是相当奇葩, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=13, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dca18435542, createdName=新来的小李, createdTime=Fri Mar 15 11:01:09 CST 2024, time=2024-03-15, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2201147, encodeId=7167220114e9e, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：外科 经验分享：1.22投的，一个月外审，三个审稿人，意见都还行，二十天的修改时间，返修第三天二审就好了，一直with editor，二十天过后接收。想问下大家，投的计量学综述，还没收到proof，还能和期刊编辑联系要求修改文章类型吗，想改成article, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=7, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=49819165911, createdName=ms3000000893685364, createdTime=Mon Apr 29 21:08:56 CST 2024, time=2024-04-29, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2165578, encodeId=7d1821655e829, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：刚被拒来发篇经验贴供各位学者参考。 本人手里一篇对标10分的原创基础研究，考虑其他杂志的审稿周期太长所以投了IJS， 7.31 submitted 8.1 under review 期间变动了很多次审稿结束 9.12 with editor 最令人发指的地方来了，从9.12一直到 10.20状态一点都没变过，忍无可忍联系了编辑部催稿，隔天就回复了说已经审完了正在做决定 10.29 直接给我转投了 更令人气愤的是，给出了两个审稿人的意见，一个审稿人觉得很好，另一个审稿人毛都没说出来只是重复了一下文章的研究结果，然后就没了 这种垃圾杂志真是头回见，原创研究还是别往这上面投了，也就水一水meta和review得了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=4b5d5469747, createdName=ms9000002081735011, createdTime=Sun Oct 29 18:19:14 CST 2023, time=2023-10-29, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2187485, encodeId=685a218e485e5, content=偏重的研究方向：手术方式 经验分享：自己投了一篇review，请问各位专家大佬这个期刊投稿reject后建议transfer，一般是转到那个期刊，大家觉得可以转投吗?感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be798767220, createdName=ms5000000507385055, createdTime=Thu Feb 15 22:54:24 CST 2024, time=2024-02-15, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2196681, encodeId=61152196681b0, content=偏重的研究方向：外科;围手术期;临床研究 经验分享：中修转小修然后3月29小修修回后后一直是with editor，有这种情况的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=18, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02026231296, createdName=172132_4262, createdTime=Tue Apr 02 20:16:42 CST 2024, time=2024-04-02, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198723, encodeId=2ece2198e2331, content=审稿速度:2.0 | 投稿命中率:95.0 偏重的研究方向：外泌体;肿瘤标志物 经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8f8a1685210, createdName=易挥发, createdTime=Tue Apr 16 08:13:50 CST 2024, time=2024-04-16, status=1, ipAttribution=广东省)]

2024-04-16 易挥发来自广东省

审稿速度:2.0 | 投稿命中率:95.0
偏重的研究方向：外泌体;肿瘤标志物
经验分享：2.29投稿，这杂志双盲审，提交的材料跟其它杂志还不太一样。3.22收到意见，3个reviewer，都比较正向。4.2返修,4.15accept

17 6

展开6条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务